216 related articles for article (PubMed ID: 17118658)
1. Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers.
Quinlan JG; Wong BL; Niemeier RT; McCullough AS; Levin L; Emanuele M
Neuromuscul Disord; 2006 Dec; 16(12):855-64. PubMed ID: 17118658
[TBL] [Abstract][Full Text] [Related]
2. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
[TBL] [Abstract][Full Text] [Related]
3. Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
Spurney CF; Guerron AD; Yu Q; Sali A; van der Meulen JH; Hoffman EP; Nagaraju K
BMC Cardiovasc Disord; 2011 May; 11():20. PubMed ID: 21575230
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
5. Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice.
Whitehead NP; Streamer M; Lusambili LI; Sachs F; Allen DG
Neuromuscul Disord; 2006 Dec; 16(12):845-54. PubMed ID: 17005404
[TBL] [Abstract][Full Text] [Related]
6. Dystrophic heart failure blocked by membrane sealant poloxamer.
Yasuda S; Townsend D; Michele DE; Favre EG; Day SM; Metzger JM
Nature; 2005 Aug; 436(7053):1025-9. PubMed ID: 16025101
[TBL] [Abstract][Full Text] [Related]
7. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice.
Hodgetts S; Radley H; Davies M; Grounds MD
Neuromuscul Disord; 2006 Oct; 16(9-10):591-602. PubMed ID: 16935507
[TBL] [Abstract][Full Text] [Related]
8. Exercise improves the success of myoblast transplantation in mdx mice.
Bouchentouf M; Benabdallah BF; Mills P; Tremblay JP
Neuromuscul Disord; 2006 Aug; 16(8):518-29. PubMed ID: 16919954
[TBL] [Abstract][Full Text] [Related]
9. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
10. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach.
Townsend D; Yasuda S; Metzger J
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):99-109. PubMed ID: 17187461
[TBL] [Abstract][Full Text] [Related]
12. Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice.
Piers AT; Lavin T; Radley-Crabb HG; Bakker AJ; Grounds MD; Pinniger GJ
Neuromuscul Disord; 2011 Feb; 21(2):132-41. PubMed ID: 21055937
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
[TBL] [Abstract][Full Text] [Related]
14. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
15. Weekly oral prednisolone improves survival and strength in male mdx mice.
Keeling RM; Golumbek PT; Streif EM; Connolly AM
Muscle Nerve; 2007 Jan; 35(1):43-8. PubMed ID: 16969833
[TBL] [Abstract][Full Text] [Related]
16. Influence of hindlimb suspension on calcium-induced contraction characteristics in dystrophin-deficient animals.
Litvinova KS; Shenkman BS
J Gravit Physiol; 2007 Jul; 14(1):P91-2. PubMed ID: 18372714
[TBL] [Abstract][Full Text] [Related]
17. Poloxamer [corrected] 188 has a deleterious effect on dystrophic skeletal muscle function.
Terry RL; Kaneb HM; Wells DJ
PLoS One; 2014; 9(3):e91221. PubMed ID: 24642557
[TBL] [Abstract][Full Text] [Related]
18. Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.
Shavlakadze T; White J; Hoh JF; Rosenthal N; Grounds MD
Mol Ther; 2004 Nov; 10(5):829-43. PubMed ID: 15509501
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy.
Marques MJ; Ferretti R; Vomero VU; Minatel E; Neto HS
Muscle Nerve; 2007 Mar; 35(3):349-53. PubMed ID: 17143878
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: a potential role in calcium buffering and sarcolemmal stability.
Matsumura CY; Pertille A; Albuquerque TC; Santo Neto H; Marques MJ
Muscle Nerve; 2009 Feb; 39(2):167-76. PubMed ID: 19145649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
